Fatal cirrhosis decompensation due to brucellosis: therapeutic issues. Maria Kosmidou, 1 Leonidas Christou 1 Markos Marangos, 2 Georgios Panos, 2 Epameinondas.

Slides:



Advertisements
Similar presentations
Acute Liver Failure.
Advertisements

Bacterial Infection in Liver Cirrhosis: the Microbiologist Point of View Prof. Marie-Hélène NICOLAS-CHANOINE.
Chronic liver disease and substance misuse
Hepatocirrhosis Liver cirrhosis.
Hcv infection and management in advanced liver disease
Chronic Liver Disease Simon Lynes. Definition Progressive destruction and regeneration of the liver parenchyma leading to fibrosis and cirrhosis.
Risё Stribling, MD Medical Director of Liver Transplant St Luke’s Medical Center Associate Professor of Surgery Baylor College of Medicine.
Hepatitis web study H EPATITIS C C URRICULUM Terry D. Box, MD Associate Professor of Medicine Division of Gastroenterology/Hepatology University of Utah.
Management of ascites in patients with cirrhosis Treviso 4 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of Padova.
Interventional Oncology Michael Kotton MD October 27, 2012.
HCV: Treat now or Defer Todd Wills, MD ETAC Infectious Disease Specialist HEPATITIS C TREATMENT EXPANSION INITIATIVE MULTISITE CONFERENCE CALL JUNE 19,
Lobna Al juffali,Msc.  Brucellosis is a worldwide zoonosis caused by infection with the bacterial genus Brucella.  It is primarily a contagious disease.
Protein GP73 (GOLGI PROTEIN 73) A NEW NON-INVASIVE BIOMARKER FOR ASSESSING LIVER FIBROSIS AND RISK OF PROGRESSION TO HEPATOCELLULAR CARCINOMA N.K. Gatselis,
CDI Education Cirrhosis 4/17/2017.
Brucellosis By: Leah Kasheta.
Complications of Liver Cirrhosis Ayman Abdo MD, AmBIM, FRCPC.
Hepatitis web study H EPATITIS W EB S TUDY Christian B. Ramers, MD, MPH Assistant Medical Director, Family Health Centers of San Diego HIV/HCV Distance.
Liver disease Prepared by: Siti Norhaiza Bt Hadzir.
CIRRHOSIS OF LIVER PORTAL HYPERTENSION HEPATIC ENCHEPALOPATHY
Greenview Hepatitis C Fund Deborah Green Home: Cell: /31/2008.
Methotrexate- induced rheumatoid nodules in the liver and spleen masquerading metastatic malignancy: a case report Maria Kosmidou 1, Paraskeyi Kotsi 1,
Hepatitis B and Acute Liver Failure Jack Kuritzky, PGY-2 UNC Internal Medicine Morning Report 3/12/10.
Autopsy Findings. Important premortem finding Blood cultures positive for Escherichia coli Ascites fluid showed numerous neutrophils –negative for bacterial.
Chronic liver disease Cirrhosis hepatic Encephalopathy Dr. Yasir M Khayyat MBcHB,FRCPC,FACP,ABIM Assistant professor of Medicine Faculty of Medicine Umm.
CROHN’S DISEASE Alison Cunliffe. What is Crohn’s Disease?  Chronic inflammatory disease of the intestines  Causes ulcerations, breaks in the lining,
+ Liver Transplantation for PSC Patients A Transplant Surgeon’s Perspective Tiffany Anthony, MD Annette C. and Harold C. Simmons Transplant Institute Baylor.
Chronic Liver Disease. Burden Markedly decreased life expectancy 12th leading cause of death in US 25,000 deaths annually in US High morbidity and mortality.
Cirrhosis 18 November 2009 Thomas C Sodeman MD Associate Professor of Medicine Chief, Division of Gastroenterology.
Hepatitis C+ Recipients: Considerations for Exclusion Emily A. Blumberg, M.D.
INTERFERENCE TO NUTRITIONAL NEEDS DUE TO DEGENERATION AND INFLAMMATION Cirrhosis and Hepatitis.
BRUCELLOSIS. Overview Brucellosis, also called undulant or Malta fever, is a prolonged febrile disease involving the reticuloendothelial system and is.
Spontaneous Bacterial Peritonitis Katherine Yu May 2014.
Complications of liver cirrhosis
September 2015 Sumiko Nagoshi Geoffrey Farrell Tomoaki Tomiya Progress Report Hepatology and PancreaticoBiliary (HPB)
Complications of liver cirrhosis
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
Blood borne Pathogens. Background  Occupational Safety and Health Administration (OSHA)  Blood borne pathogen standard developed December 6, 1991 
Management of patients with cirrhosis and refractory ascites Treviso 4 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of.
INTRODUCTION Alcohol-induced liver disease is the most common type of drug-induced liver disease. All other drugs together account for less than 10% of.
Complications of liver cirrhosis. Recognize the major complications of cirrhosis. Understand the pathological mechanisms underlying the occurrence of.
INTERNAL MEDICINE BENJAMIN YIP 4/13/16 Mini Lecture: Hepatorenal Syndrome.
CIRRHOSIS MANAGEMENT FOR HOSPITALISTS Madhav Devani 6/7/16.
HBV & HCV induced Liver Cirrhosis Iradj Maleki MD Gut & Liver Research Center Mazandaran University of Medical Sciences.
Viral Hepatitis.
Intern Report Patient Presentation  55yM no PMH presenting with worsening abdominal pain for 2-3 days. Describes pain as diffuse, non-radiation,
National Hepatitis C Database
Bachar Samra MD1, Jacques Azzi MD1, Ambreen Khalil MD2.
Abstract Category: Liver
Phase 3 Treatment-Naïve and Treatment-Experienced
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
Acute hepatitis of uncertain cause, rule out EBV related
Managing Complications of Cirrhosis
Chapter 12 Liver Transplantation 1
Orthotopic liver transplant, recurrent non-alcoholic steatohepatitis
Spontaneous Bacterial Peritonitis
Multiple factors can predispose to decompensation in a patient with cirrhosis. Risk factors for decompensation include: Bleeding Infection Alcohol.
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
Figure 2 The concept of the hepatic reserve and ACLF
R Moreau, L Elkrief, C Bureau et al. Gastroenterology. Aug [Epub]
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Impact of metabolic risk factors on HCC
Alcoholic Hepatitis (1)
Trends in the management and burden of alcoholic liver disease
Internal medicine L-4 Liver cirrhosis & portal hypertension
Phase 3 Treatment-Naïve and Treatment-Experienced
The Liver in Brucellosis
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
Management of cirrhosis
LIVER CIRRHOSIS IN PSC: DIAGNOSIS AND MANAGEMENT
Presentation transcript:

Fatal cirrhosis decompensation due to brucellosis: therapeutic issues. Maria Kosmidou, 1 Leonidas Christou 1 Markos Marangos, 2 Georgios Panos, 2 Epameinondas V Tsianos 1 1 : Department of Internal Medicine, Medical School, University of Ioannina, Greece 2 : Department of Infectious Diseases, Medical School, University of Patras, Greece

Brucellosis: prevalent zoonotic disease worldwide, still endemic in Greece and the Balkans Known opportunistic infection in patients with hematologic or chronic rheumatologic diseases Affinity for reticuloendothelial system (RES) which includes the liver and peritoneal phagocytic system Liver involvement mild typically in brucellosis, sometimes induces benign granulomas, rare chronic hepatosuppurative disease, known predisposition to spontaneous bacterial peritonitis (SBP in patients with underlying liver disease Need for combined, protracted antibiotic treatment with potentially hepatotoxic agents

The new global map of human brucellosis Pappas G, et al, Lancet Infect Dis 2006

Liver biopsy. Arrows indicate 2 epithelioid granulomas within the parenchyma (hematoxylin-eosin, 200). Liver biopsy. Note dense lymphocytic infiltrates in the portal areas (hematoxylin-eosin, 200). Hepatic involvement in brucellosis Akritidis N, et al, Clin Gastroenterol Hepatol 2007

Three cases of cirrhosis decompensation in the course of brucellosis (direct, due to the infection, or indirect, due to antibiotics’ adverse effects) Not all cirrhotics are decompensated during the course of brucellosis (numerous cases, even with HCC, successfully treated)- this case series presents mechanisms of decompensation

Case 1: 47-year male, alcoholic cirrhosis, compensated for >6 months, also IDDM Evening fever, abdominal dilatation US: Ascites, splenomegaly, no portal thrombosis Peritoneal fluid cultures: Brucella melitensis (recalled consumption of unpasteurised dairy products) Treatment:? (history of tetracycline intolerance) TMP-SMX + CIPRO: initial response, relapse on day 12- substitute TMP-SMX with DOX (salvage)- remission- outpatient- day 40 encephalopathy-death Encephalopathy induced either by antibiotic hepatotoxicity or by disease relapse (no autopsy)

Case 2: 50-year male, alcoholic cirrhosis with no complication history, shepherd Mild fever and abdominal distention Blood cultures: Brucella melitensis Aggressive treatment: DOX +RIF 600+ CIPRO- symptom remission on day 5- progressive increase in LFTs/INR- lowering RIF to 300 Day 41: encephalopathy, bilirubin total 16mg/dl, further INR increase- stop antibiotics Referral for transplant- transplant performed/ perioperative fatal event Encephalopathy induced potentially by antibiotic hepatotoxicity

Case 3: 46-year male, novel diagnosis of alcoholic cirrhosis Persistent low fever, trip to Spain and consumption of unpasteurised dairy products 2months ago Blood cultures: Brucella melitensis Treatment: DOX + CIPRO- day 4 massive increase in LFTs and DIC- death on day 33 post encephalopathy and spontaneous intracranial hemorrhage DIC induced potentially by infection (known complication of brucellosis)

No currently acceptable regimen can be used safely: Potential hepatotoxicity of DOX/RIF Potential for hepatorenal syndrome By AMGs DOX+ STR or GENT Not safe, DOX + RIF Not safe What to do? Awareness for a potentially fatal opportunistic infection Enhancement of patient health literacy in order to prevent exposure and infection